212 related articles for article (PubMed ID: 15191788)
21. Determination of intraluminal theophylline concentrations after oral intake of an immediate- and a slow-release dosage form.
Brouwers J; Ingels F; Tack J; Augustijns P
J Pharm Pharmacol; 2005 Aug; 57(8):987-96. PubMed ID: 16102254
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the performance of controlled release dosage forms of ticlopidine using in vitro intestinal permeability and computer simulations.
Grass GM; Bozarth CA; Vallner JJ
J Drug Target; 1994; 2(1):23-33. PubMed ID: 8069581
[TBL] [Abstract][Full Text] [Related]
23. Physiology and pharmacology of the brushtail possum gastrointestinal tract: relationship to the human gastrointestinal tract.
McDowell A; McLeod BJ
Adv Drug Deliv Rev; 2007 Sep; 59(11):1121-32. PubMed ID: 17870201
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of in vivo dissolution behavior and GI transit of griseofulvin, a BCS class II drug.
Fujioka Y; Metsugi Y; Ogawara K; Higaki K; Kimura T
Int J Pharm; 2008 Mar; 352(1-2):36-43. PubMed ID: 18037251
[TBL] [Abstract][Full Text] [Related]
25. A physiological model for the estimation of the fraction dose absorbed in humans.
Willmann S; Schmitt W; Keldenich J; Lippert J; Dressman JB
J Med Chem; 2004 Jul; 47(16):4022-31. PubMed ID: 15267240
[TBL] [Abstract][Full Text] [Related]
26. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
[TBL] [Abstract][Full Text] [Related]
27. Modeling and Monte Carlo simulations in oral drug absorption.
Dokoumetzidis A; Kosmidis K; Argyrakis P; Macheras P
Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):200-5. PubMed ID: 15733215
[TBL] [Abstract][Full Text] [Related]
28. Novel oral drug formulations. Their potential in modulating adverse effects.
Florence AT; Jani PU
Drug Saf; 1994 Mar; 10(3):233-66. PubMed ID: 8043223
[TBL] [Abstract][Full Text] [Related]
29. Characterization of gastrointestinal drug absorption in cynomolgus monkeys.
Takahashi M; Washio T; Suzuki N; Igeta K; Fujii Y; Hayashi M; Shirasaka Y; Yamashita S
Mol Pharm; 2008; 5(2):340-8. PubMed ID: 18247527
[TBL] [Abstract][Full Text] [Related]
30. [Biopharmaceutical considerations of dissolution testing used as a prognostic tool for oral drug adsorption].
Antal I
Acta Pharm Hung; 2001 Oct; 71(3):280-8. PubMed ID: 11961894
[TBL] [Abstract][Full Text] [Related]
31. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models.
Dokoumetzidis A; Kalantzi L; Fotaki N
Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):491-505. PubMed ID: 17696801
[TBL] [Abstract][Full Text] [Related]
32. Alginate microspheres of isoniazid for oral sustained drug delivery.
Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
[TBL] [Abstract][Full Text] [Related]
33. Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation.
Chavanpatil M; Jain P; Chaudhari S; Shear R; Vavia P
Int J Pharm; 2005 Nov; 304(1-2):178-84. PubMed ID: 16198522
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of gastrointestinal absorption of poorly water soluble drugs via lipid based systems.
Subramanian N; Ghosal SK
Indian J Exp Biol; 2004 Nov; 42(11):1056-65. PubMed ID: 15587110
[TBL] [Abstract][Full Text] [Related]
35. [Investigation of the in vivo desintegration and transit behavior of tetramethylpyrazine phosphate pulsincap capsule in the gastrointestinal tract of dogs by gamma scintigraphy].
Wu F; Ding H; Zhang Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Aug; 23(4):790-4. PubMed ID: 17002109
[TBL] [Abstract][Full Text] [Related]
36. Estimating drug solubility in the gastrointestinal tract.
Dressman JB; Vertzoni M; Goumas K; Reppas C
Adv Drug Deliv Rev; 2007 Jul; 59(7):591-602. PubMed ID: 17599644
[TBL] [Abstract][Full Text] [Related]
37. Analysis of gastrointestinal physiology using a novel intestinal transit assay in zebrafish.
Field HA; Kelley KA; Martell L; Goldstein AM; Serluca FC
Neurogastroenterol Motil; 2009 Mar; 21(3):304-12. PubMed ID: 19140958
[TBL] [Abstract][Full Text] [Related]
38. Investigation of human pharmacoscintigraphic behavior of two tablets and a capsule formulation of a high dose, poorly water soluble/highly permeable drug (efavirenz).
Gao JZh; Hussain MA; Motheram R; Gray DA; Benedek IH; Fiske WD; Doll WJ; Sandefer E; Page RC; Digenis GA
J Pharm Sci; 2007 Nov; 96(11):2970-7. PubMed ID: 17542016
[TBL] [Abstract][Full Text] [Related]
39. Intracisternal des-acyl ghrelin inhibits food intake and non-nutrient gastric emptying in conscious rats.
Chen CY; Chao Y; Chang FY; Chien EJ; Lee SD; Doong ML
Int J Mol Med; 2005 Oct; 16(4):695-9. PubMed ID: 16142407
[TBL] [Abstract][Full Text] [Related]
40. The delayed dissolution of paracetamol products in the canine fed stomach can be predicted in vitro but it does not affect the onset of plasma levels.
Kalantzi L; Polentarutti B; Albery T; Laitmer D; Abrahamsson B; Dressman J; Reppas C
Int J Pharm; 2005 May; 296(1-2):87-93. PubMed ID: 15885459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
